Evaluation of fecal microRNA stability in healthy cats

BACKGROUND: Gastrointestinal (GI) cancer accounts for 14% of feline malignancies. There is a great need for reliable noninvasive diagnostic biomarkers to reach a timely diagnosis and initiate treatment. Fecal microRNAs (miRNAs) could be such a biomarker and have shown great potential in colorectal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyngby, Janne G., Kristensen, Annemarie T., Fredholm, Merete, Nielsen, Lise N., Cirera, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Biomarker Discovery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852515/
https://www.ncbi.nlm.nih.gov/pubmed/31241203
http://dx.doi.org/10.1111/vcp.12757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852515/
https://www.ncbi.nlm.nih.gov/pubmed/31241203
http://dx.doi.org/10.1111/vcp.12757

Ejemplares similares